Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2010
08/26/2010US20100216977 Therapeutic agent for interstitial pulmonary disease comprising anti-hmgb-1 antibody
08/26/2010US20100216976 Sodium-independent transporter carrying acidic amino acid and its gene
08/26/2010US20100216975 Framework-Shuffling Of Antibodies
08/26/2010US20100216974 Binding molecules
08/26/2010US20100216720 Antibodies to troponin i and methods of use thereof
08/26/2010US20100216716 Cell-Permeable Peptide Inhibitors Of The JNK Signal Transduction Pathway
08/26/2010US20100216714 Natriuretic compounds, conjugates, and uses thereof
08/26/2010US20100216713 Novel compositions and methods in cancer associated with altered expression of prlr
08/26/2010US20100216704 Novel genes and proteins that home to developing microvessels
08/26/2010US20100216187 Amino acid sequences that bind to a desired molecule in a conditional manner
08/26/2010US20100216170 Methods for identifying immunobinders of cell-surface antigens
08/26/2010US20100216154 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
08/26/2010US20100216140 Novel Human Dickkopf-Related Protein and Nucleic Acid Molecules and uses Therefor
08/26/2010US20100215696 Efficiently replicable heptitis c virus mutant, a heptitis c virus mutant comprising reporter gene, a method of preparing of hcv vaccine using the same and a method of screening anti hcv composition using the same
08/26/2010US20100215684 Streptococcus m protein, immunogenic fragments, nucleic acids and methods of use
08/26/2010US20100215680 Replikin peptides and antibodies therefor
08/26/2010US20100215675 Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
08/26/2010US20100215670 Immunotoxin Fusions Comprising An Antibody Fragment and a Plant Toxin Linked by Protease Cleavable Linkers
08/26/2010US20100215669 Anti-cd79b antibodies and immunoconjugates and methods of use
08/26/2010US20100215667 Methods and compositions of treatment for modulating the immune system of animals
08/26/2010US20100215666 Il-17 antagonistic antibodies
08/26/2010US20100215664 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6 -mediated signalling
08/26/2010US20100215662 Anti-influenza M2e antibody
08/26/2010US20100215658 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same
08/26/2010US20100215657 Methods and Compositions Using Klotho-FGF Fusion Polypeptides
08/26/2010US20100215656 Deletions in domain ii of pseudomonas exotoxin a that remove immunogenic epitopes
08/26/2010US20100215654 Methods of treating Osteoarthritis with IL-6 Antagonists
08/26/2010US20100215651 Humanized antibodies that bind to CD19 and their uses
08/26/2010US20100215649 Antibodies for norovirus
08/26/2010US20100215648 Detecting Agent and Therapeutic Agent for Highly Malignant Breast Cancer
08/26/2010US20100215647 Immunological Compositions as Cancer Biomarkers and/or Therapeutics
08/26/2010US20100215645 determining increased risk for developing positive autoantibody rheumatoid factor (RF+) Rheumatoid Arthritis (RA) in human by testing nucleic acid from the human to detect the nucleotide content of a single nucleotide polymorphism (SNP) at position 101 of any of SEQ ID NOS:10,916-49,582 and 50,231
08/26/2010US20100215641 Screening method for compounds that reduce er stress
08/26/2010US20100215581 Contrast agents for detecting prostate cancer
08/26/2010US20100215576 Diagnosis and treatment of neuroectodermal tumors
08/26/2010US20100215573 Igf-1r specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
08/26/2010CA2767752A1 Improved anti-serum albumin binding variants
08/26/2010CA2753294A1 Proproteins and methods of use thereof
08/26/2010CA2753280A1 Anti-human .alpha.9 integrin antibody and use thereof
08/26/2010CA2753172A1 Means for purifying a protein of blood plasma and methods for implementing same
08/26/2010CA2753158A1 Humanized antibodies that bind to cd19 and their uses
08/26/2010CA2753130A1 Improved anti-serum albumin binding variants
08/26/2010CA2753048A1 Streptavidin having low immunogenicity and use thereof
08/26/2010CA2752815A1 Antibodies to clostridium difficile toxins
08/26/2010CA2752584A1 Specific binding proteins and uses thereof
08/26/2010CA2752171A1 Method for inhibiting neurodegeneration
08/26/2010CA2751669A1 Method for obtaining immunoglobulin encoding nucleic acid
08/26/2010CA2751477A1 Antibody molecules having specificity for human ox40
08/26/2010CA2751311A1 Means and methods for manufacturing highly pure neurotoxin
08/26/2010CA2750985A1 Methods and compositions for diagnosis and treatment of cancer
08/26/2010CA2750477A1 Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists
08/25/2010EP2221619A1 Anti-drug antibody assay
08/25/2010EP2221384A1 Method for production of antibody
08/25/2010EP2221375A1 Methods and compositions for diagnosis and treatment of cancer
08/25/2010EP2221374A1 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
08/25/2010EP2221317A2 PEGylated single domain antibodies (dAb)
08/25/2010EP2221316A1 Anti-CD19 antibody therapy for autoimmune disease
08/25/2010EP2221315A1 Methods of generating variant proteins with increased host string content and compositions thereof
08/25/2010EP2221064A1 Humanized antibodies that recognize beta amyloid peptide
08/25/2010EP2220247A2 Antibodies to lrp6
08/25/2010EP2220125A2 Production of fc-fusion polypeptides in eukaryotic algae
08/25/2010EP2220124A2 Biomarker detection
08/25/2010EP2220123A1 Compositions and methods for inhibiting tumor progression
08/25/2010EP2220122A2 Humanized antibodies against tl1a
08/25/2010EP2220120A2 Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
08/25/2010EP2220119A2 Anti-igf antibodies that bind to igf-1 and igf-2 but not to insulin
08/25/2010EP2220118A2 Wise binding antibodies and epitopes
08/25/2010EP2220117A2 Antibodies to the pcrv antigen of pseudomonas aeruginosa
08/25/2010EP2220116A1 Compositions and methods for the therapy and diagnosis of influenza
08/25/2010EP2220115A2 Polypeptides, antibody variable domains & antagonists
08/25/2010EP2220114A1 Anti-vegf antibodies
08/25/2010EP2220063A1 Mycophenolic acid immunogens and antibodies
08/25/2010EP2219672A1 Anti-vegf antibody compositions and methods
08/25/2010EP2219628A1 Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (tlx)
08/25/2010EP2219458A1 Compositions and methods for generating antibodies
08/25/2010EP1697516B1 Maize metallothionein promoter
08/25/2010EP1469882B1 Treatment of nervous system diseases with goat serum
08/25/2010EP1404367B1 Use of polyclonal anti-hiv goat serum as a therapeutic agent
08/25/2010EP1100529B2 Thymosin beta 4 promotes wound repair
08/25/2010EP1075513B1 Continuous in vitro evolution
08/25/2010CN1871518B Method of detecting hepatitis c virus
08/25/2010CN101815786A Protein expression from multiple nucleic acids
08/25/2010CN101815726A Monoclonal antibodies against glypican-3
08/25/2010CN101815725A anti cd37 antibodies
08/25/2010CN101815530A Therapeutic antibody purification method and method of use
08/25/2010CN101812460A Gene sequence of rachycentron canadus MHC-IIalpha immune globulin Mu chain
08/25/2010CN101812134A Antibodies that bind cell-associated ca 125/0722p and methods of use thereof
08/25/2010CN101812133A Receptor, the use thereof, and mouse antibodies
08/25/2010CN101812132A Humanized neutralizing antibody (RVFab3) against rabies virus glycoprotein
08/25/2010CN101812131A Humanized neutralizing antibody (RVFab8) against rabies virus glycoprotein
08/25/2010CN101812130A Humanized neutralizing antibody (RVFab5) against rabies virus glycoprotein
08/25/2010CN101812129A Monoclonal antibody for hand-foot-mouth EV71 virus and application thereof
08/25/2010CN101812128A Valnemulin artificial antigen and preparation method and application thereof
08/25/2010CN101812118A Specific binding agents of human angiopoietin-2
08/25/2010CN101200709B Hybridoma cell line against akabane virus monoclonal antibody, monoclonal antibody as well as reagent kit and uses thereof
08/24/2010USRE41555 Antibody purification
08/24/2010US7781574 chimeric nucleic acid sequence encoding a polypeptide comprising a nuclear localization signal of a viral protein and a fragment of an osteogenic factor having osteogenic activity; for treating disc disease associated with trauma or disc degeneration
08/24/2010US7781570 antibody produced in response to the derivative; effective tool in the guidance is the monitoring of aminoglycoside concentration in the biological fluid of a treated patient
08/24/2010US7781569 inhibiting proliferation of a antigenmyeloma tumor cell expressing a ganglioside by contacting the cell with an antibody that specifically binds to the ganglioside; melanoma, myeloma, small cell lung cancer, thymic lymphoma, T-cell lymphoma, B-cell lymphoma, osteosarcoma, and acute T-cell leukemia
08/24/2010US7781568 single chain Fv antibodies which specifically binds the extracellular domain of MISIIR; imaging cancer, particularly ovarian cancer
1 ... 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 ... 1494